追踪活检前双参数前列腺MRI后临床实践模式的变化
这项回顾性单中心研究纳入2015年10月至2018年3月间1661例疑似前列腺癌患者,评估活检前双参数MRI实施后临床实践的变化。结果显示活检前MRI使用比例从第1期的22.6%升至第5期的84.4%,根据MRI结果避免活检的比例从9.0%升至48.1%(均P<0.001)。阴性MRI组前列腺癌检出率和阳性针数低于阳性MRI组和无活检前MRI组。
要点
- 活检前双参数MRI使用比例从第1期22.6%升至第5期84.4%(P<0.001)。
- 根据MRI结果避免活检的比例从第1期9.0%升至第5期48.1%(P<0.001)。
- 阴性MRI组前列腺癌检出率和阳性针数低于阳性MRI组和无活检前MRI组。
临床应用与阅片要点
- 原文结论认为活检前双参数MRI方案已良好适应实践,并有助于对临床显著前列腺癌的概率进行分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the change in clinical practice after implementation of prebiopsy biparametric MRI followed by targeted biopsy and the benefits of prebiopsy MRI based on real clinical practice.
MATERIALS AND METHODS: A total of 1,661 patients who underwent either transrectal biopsy or prebiopsy MRI for suspected prostate cancer between October 2015 and March 2018 were enrolled in this retrospective single-center study. To evaluate temporal changes in clinical practice, the study time was divided into five periods of six months. Prebiopsy prostate MRI was officially started in April 2016 in this center. Differences in practice patterns were compared among the five periods, and differences in biopsy results were compared in three groups: no prebiopsy MRI, negative MRI and positive MRI.
RESULTS: Prostate cancers were diagnosed in 463 patients. The proportion of patients who underwent prebiopsy MRI regardless of biopsy increased from 22.6% in period 1 to 84.4% in period 5 (P < 0.001). The proportion of patients who avoided biopsy according to MRI results increased significantly from 9.0% in period 1 to 48.1% in period 5 (P < 0.001). The prostate cancer detection rate and the number of positive cores were lower in the negative MRI group than those in the positive MRI and no prebiopsy MRI groups.
CONCLUSION: Prebiopsy MRI using biparametric MRI protocol has been well adapted to the practice and it is useful in stratifying the probability of clinically significant prostate cancer.
引用
- Choi MH, Lee YJ, Jung SE, et al. Tracking Changes in Clinical Practice Patterns Following Prebiopsy Biparametric Prostate MRI. Acad Radiol. 2019. PMID: 31812576. doi:10.1016/j.acra.2019.10.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。